Primary aldosteronism and low-renin hypertension: A continuum?

Nephrology Dialysis Transplantation

Volumn 28, Issue 7, 2013, Pages 1625-1627

  Funder, John W ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Aldosterone renin ratio; Between patient variability; Low renin hypertension; Mineralocorticoid receptors; Primary aldosteronism

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; EPLERENONE; RENIN; SPIRONOLACTONE;

ALDOSTERONE BLOOD LEVEL; ARTICLE; CARDIOVASCULAR EFFECT; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HYPERTENSION; LOW DRUG DOSE; LOW RENIN HYPERTENSION; NONHUMAN; NORMAL VALUE; PATIENT SELECTION; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; TREATMENT OUTCOME;

ALDOSTERONE-RENIN RATIO; BETWEEN-PATIENT VARIABILITY; LOW-RENIN HYPERTENSION; MINERALOCORTICOID RECEPTORS; PRIMARY ALDOSTERONISM;

FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; RENIN; SPIRONOLACTONE;

EID: 84884527998     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft052     Document Type: Article

References (8)

1. Milliez P, Girerd X, Plouin PF et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243-1248
2. Ori Y, Chagnac A, Korzets A et al. Regression of ventricular hypertrophy/low renin hypertension patients with primary aldosteronism on low dose spironolactone. Nephrol Dial Transplant 2013; 28: 1787-1793
3. Levy D, Rocha R, Funder JW. Distinguishing the antihypertensive and electrolyte effects of eplerenone. J Clin Endocrinol Metab 2004; 89: 2736-2740
4. Rossi GP, Bernini G, Caliumi C et al. PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1125 patients. J Am Coll Cardiol 2006; 48: 2293-2300
5. Gouli A, Kaltsas G, Tzunov A et al. High prevalence of autonomous aldosterone secretion among patients with essential hypertension. Eur J Clin Invest 2011; 44: 1227-1236
6. Mihailidou AS, Le TYL, Mardini M et al. Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 2009; 54: 1306-1312
7. Le TYL, Mardini M, Howell VM et al. Low dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction. Hypertension 2012; 59: 1164-1169
8. Funder JW, Carey RM, Fardella C et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266-3281